Oorsprong van het eerstegraads netwerk van Herbert Müsch
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
RESprotect GmbH
RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany.
9
| Holding Company | Pharmaceuticals: Other | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Herbert Müsch via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
UroTiss GmbH
UroTiss GmbH Medical/Nursing ServicesHealth Services UroTiss Gmbh researches, develops, and manufactures pharmaceuticals for the treatment of urethral strictures and hypospadias. The company was founded by Dr. Gouya Ram-Liebig in 2005 and is headquartered in Dortmund, Germany. | Medical/Nursing Services | Director of Finance/CFO | |
PROPANC BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Bonn | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Duitsland | 3 |
Australië | 2 |
Sectoraal
Health Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Operationeel
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Director of Finance/CFO | 2 |
Chief Executive Officer | 1 |
Founder | 1 |
Sterkste connecties
- Beurs
- Insiders
- Herbert Müsch
- Bedrijfsconnecties